Eric S Fain insider trades
Open-market stock purchases and sales by Eric S Fain, Director at Orchestra BioMed Holdings, Inc, from SEC Form 4 filings since Jul 1, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +22%.